Healthcare Technology

Contineum Therapeutics' IPO success reflects investor confidence in their innovative therapies for neuroscience, inflammation, and immunology.

J&J acquires Shockwave Medical for $13.1B, bolstering its medical device portfolio and positioning retail investors for potential growth in the...

Activist investor Carl Icahn spares Illumina a second proxy contest, but continues lawsuit, leaving retail investors curious about board dynamics...

Jabil (JBL) stock shines in the S&P 500 with growth in the healthcare and EV sectors, robust financials, and a strong market outlook.

The IPOs to look out for this week include electric bicycle makers SONDORS, drone developers ParaZero Technologies and medicine development and AI...

Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...

In a topsy turvy week for its share price, NanoVibronix (NASDAQ: NAOV) shares have lost ground on Tuesday after the company secured new investment.

Constellation Software (TSE: CSU) is a hot Canadian tech stock with a savvy M&A strategy that keeps it a favorite among tech investors.

DexCom (NASDAQ: DXCM) is on the up after its third quarter saw sales growth and continued international expansion. But is DXCM stock a good...

This week's expected IPOs include possible listings from Wearable Devices (NASDAQ: WLDS) and Know Labs (NYSEAMERICAN: KNW).

Few had heard of myocarditis before the pandemic, but now it’s a serious worry making global headlines. One company is hoping to treat it.

Poor air quality, in part caused by issues surrounding climate change, has forced these healthcare companies into looking at ways to combat heart...

Aditxt Inc has seen its share price leap by more than 70% on Friday following the completion of a toxicology study. But what's the story behind...

Find out more about how Merck (NYSE: MRK), Bio-Techne Corporation (NASDAQ: TECH), Natera (NASDAQ: NTRA) and Cardiol Therapeutics (NASDAQ: CRDL)...

Our 'Key Themes For 2022' is designed to help you identify and capitalise on the areas to watch out for. Here we have healthcare.

Though markets recovered well on Monday concerns about the newly emerged Omicron COVID variant have sent futures lower as investors worry that...